Mixed phenotype acute leukemia has qualities of both lymphoid and myeloid leukemias. These mixed qualities make it very difficult to diagnose and treat. The outlook for people with this type of ...

Biphenotypic leukemia is a mixed type of leukemia that originates in both lymphoid and myeloid cells. It typically has a poorer outlook than other acute leukemias. A stem cell transplant may improve ...

September is Leukemia and Lymphoma Awareness Month. An estimated 1,629,474 people in the United States (US) are living with or in remission from leukemia, lymphoma, myeloma, myelodysplastic syndromes ...

Leukemia is a cancer of the blood-forming tissues that often develops in the bone marrow. It affects cells that develop into ...

Researchers used various sequencing technologies to explore the molecular characteristics of myeloid/natural killer cell precursor acute leukemia (MNKPL). They observed activation of the NOTCH1 and ...

Doctors determine the stage of leukemia by evaluating factors such as the number of leukemia cells in the blood and bone marrow, the spread of leukemia to other parts of the body, and the person’s ...

Leukemia is a blood cancer with abnormal white blood cell overproduction, affecting red blood cells and platelets, leading to anemia and infection risks. Diagnosis involves blood tests, bone marrow ...

Anthony, a 60 year old male, started to notice that he was frequently becoming more tired the past few months. His sister noticed that Anthony was getting bruises on his arms and legs, and was ...

Share on Pinterest Scientists are testing new drugs to treat different types of leukemia. Luis Velasco/Stocksy More than 474,000 people globally have leukemia, and acute leukemia is the most ...

Q: My mother was diagnosed with CLL two years ago. She started chemotherapy. The drug ratuximab is her current chemotherapy drug. She has also developed lymphoma. Approximately six months ago she ...

Researchers of the Hospital Universitario 12 de Octubre in Madrid and the Josep Carreras Leukaemia Research Institute have developed a cell therapy for a type of leukemia which currently has very few ...